Follow
Qlife Holding AB
Nasdaq First North GM (Sweden)
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Exercise
Price
17.50 SEK
Exercise period(s)
03 May - 31 May 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
QLIFE
SE0013486552
Nasdaq First North GM
Sweden (SE)
Details of share in Qlife Holding AB with ticker QLIFE
Status
Active
Order book id
Amount of instruments
11 174 438
Par value
Currency
SEK
First trading date
02 Mar 2020
Type
Price
Pre-money
Time
Files
IPO
12.30 SEK
82.43M SEK
20 Jan - 07 Feb 2020
IPO in Qlife Holding AB
Type
Price
Pre-money
Time
Files
Directed issue
42.00 SEK
469.33M SEK
29 Apr 2021
Share issue in Qlife Holding AB
Type
Price
Pre-money
Time
Files
Exercise
17.50 SEK
195.55M SEK
03 May - 31 May 2021
Option exercise terms for QLIFE TO1
Type
Ticker
ISIN
Market
SHARE
QLIFE
SE0013486552
Nasdaq First North GM
Sweden (SE)
Details of share in Qlife Holding AB with ticker QLIFE
Status
Active
Order book id
Amount of instruments
11 174 438
Par value
Currency
SEK
First trading date
02 Mar 2020
Type
Price
Pre-money
Time
Files
IPO
12.30 SEK
82.43M SEK
20 Jan - 07 Feb 2020
IPO in Qlife Holding AB
Type
Price
Pre-money
Time
Files
Directed issue
42.00 SEK
469.33M SEK
29 Apr 2021
Share issue in Qlife Holding AB
Type
Ticker
ISIN
Market
OPTION
QLIFE TO1
SE0013719333
Nasdaq First North GM
Sweden (SE)
Details of option in Qlife Holding AB with ticker QLIFE TO1
Status
Archived
Order book id
190668
Amount of instruments
4 472 600
Currency
SEK
Trading period
02 Mar 2020 - 27 May 2021
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share in the Company for SEK 17.50 per share during the subscription period from May 3, 2021 until May 31, 2021.
Update (03.05.2021): Subscription of warrants in Qlife Holding AB series TO 1 commences today, May 3, 2021.
Type
Price
Pre-money
Time
Files
Exercise
17.50 SEK
195.55M SEK
03 May - 31 May 2021
Option exercise terms for QLIFE TO1
People
Thomas Warthoe
CEO
Mette Gross
Chairman of the board
Niklas Marschall
Board member
John Moll
Board member
Company Details
Sector
HEALTH CARE

Address
Hamntorget 3
Zip code
252 21
City/district
Helsingborg
Country
Sweden (SE)
Registration number
559224-8040
LEI code
Qlife Holding AB
First trade date
02 Mar 2020
Registration date
31 Oct 2019
Short name
Qlife

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More